|
DENND5A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.813640E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.884100E-03 |
| Normal-vs-Stage2 |
5.246800E-01 |
| Normal-vs-Stage3 |
1.196580E-01 |
| Normal-vs-Stage4 |
5.848600E-01 |
| Stage1-vs-Stage2 |
2.723900E-02 |
| Stage1-vs-Stage3 |
6.224900E-03 |
| Stage1-vs-Stage4 |
6.035200E-01 |
| Stage2-vs-Stage3 |
5.142800E-01 |
| Stage2-vs-Stage4 |
4.051400E-01 |
| Stage3-vs-Stage4 |
1.835390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.825900E-02 |
| Normal-vs-AfricanAmerican |
7.388400E-01 |
| Normal-vs-Asian |
8.857800E-01 |
| Caucasian-vs-AfricanAmerican |
3.758200E-01 |
| Caucasian-vs-Asian |
7.493600E-01 |
| AfricanAmerican-vs-Asian |
9.953800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.162000E-03 |
| Normal-vs-Female |
1.035790E-01 |
| Male-vs-Female |
3.786900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.453200E-01 |
| Normal-vs-Extreme_Weight |
5.698800E-03 |
| Normal-vs-Obese |
9.249000E-01 |
| Normal-vs-Extreme_Obese |
1.210490E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.348400E-01 |
| Normal_Weight-vs-Obese |
4.649600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.972400E-01 |
| Extreme_Weight-vs-Obese |
2.524500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.948400E-01 |
| Obese-vs-Extreme_Obese |
1.433180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.097760E-01 |
| Normal-vs-Age(41-60Yrs) |
9.341600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.275200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.246070E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.783900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.470460E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.277580E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.397700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.002620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.102600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.239300E-03 |
| Normal-VS-Type2 PRCC |
5.382200E-01 |
| Normal-VS-KIRP CIMP |
3.295900E-02 |
| Normal-VS-Unclassified PRCC |
1.275610E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.056000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.821500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.203300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.383600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.229800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.411850E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.534300E-02 |
| Normal-vs-N1 |
1.627570E-01 |
| Normal-vs-N2 |
5.288800E-01 |
| N0-vs-N1 |
2.908200E-02 |
| N0-vs-N2 |
1.102030E-01 |
| N1-vs-N2 |
9.659200E-01 |
|
|
